It’s a clever use of 21st century digital communications media. But does this new media serve Shakespeare’s message or distort it? That is the question. It’s a big one. And it can wait.
For now, let’s talk about the play.
The play opens with mob scene. Roman plebes press into a courtyard shouting out for “Caesar!” (Merri Rashoyan). When their living idol fails to appear, they shout louder and clap and stomp like angry Metallica fans. Cinna (Bryan Lewis) and Messala (Emily Bohn) try to reason with them. The two senators don’t get very far. When Caesar finally shows, the crowd goes wild. It’s a sharp snapshot of mindless mob psychology and the threat it represents.
What s happening in the arts Sarasota-Manatee for April 8-14
heraldtribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from heraldtribune.com Daily Mail and Mail on Sunday newspapers.
Music, theater, art and more in the Sarasota-Manatee area
heraldtribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from heraldtribune.com Daily Mail and Mail on Sunday newspapers.
Medical Diagnostic Laboratories, L.L.C., (MDL), member of Genesis Biotechnology Group
® (GBG) and CLIA-certified, CAP-accredited laboratory specializing in high-complexity, state-of-the-art, automated DNA-based molecular analyses, launched a new line of testing for the field of Urology. This testing, available through
Uroveda Institute of Urogenital Diseases, an MDL Center of Excellence, blends DNA-based molecular testing with traditional pathology and cytology tests to aid in diagnosing or screening for urologic conditions.
Genesis Biotechnology Group
According to the National Institutes of Health (NIH), medical care costs for urologic diseases in the United States neared $11 billion in 2020. Urologic malignancies such as prostate, bladder, and renal cancers present challenges in diagnoses, treatment decisions, monitoring, and recurrence testing. Prostate, bladder, and renal cancers rank second, seventh, and ninth, respectively, in the top 10 cancers in the US based on new